Prevention of nausea and vomiting in cisplatin-treated patients by a selective 5-hydroxytryptamine (5-HT3) receptor antagonist, ICS 205-930

L. Dogliotti, R. Faggiuolo, A. Berruti, R. A. Antonacci, C. Ortega, I. Lancranjan

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)595-598
Number of pages4
JournalTumori
Volume76
Issue number6
Publication statusPublished - 1990

ASJC Scopus subject areas

  • Cancer Research

Cite this

Dogliotti, L., Faggiuolo, R., Berruti, A., Antonacci, R. A., Ortega, C., & Lancranjan, I. (1990). Prevention of nausea and vomiting in cisplatin-treated patients by a selective 5-hydroxytryptamine (5-HT3) receptor antagonist, ICS 205-930. Tumori, 76(6), 595-598.

Prevention of nausea and vomiting in cisplatin-treated patients by a selective 5-hydroxytryptamine (5-HT3) receptor antagonist, ICS 205-930. / Dogliotti, L.; Faggiuolo, R.; Berruti, A.; Antonacci, R. A.; Ortega, C.; Lancranjan, I.

In: Tumori, Vol. 76, No. 6, 1990, p. 595-598.

Research output: Contribution to journalArticle

Dogliotti, L, Faggiuolo, R, Berruti, A, Antonacci, RA, Ortega, C & Lancranjan, I 1990, 'Prevention of nausea and vomiting in cisplatin-treated patients by a selective 5-hydroxytryptamine (5-HT3) receptor antagonist, ICS 205-930', Tumori, vol. 76, no. 6, pp. 595-598.
Dogliotti L, Faggiuolo R, Berruti A, Antonacci RA, Ortega C, Lancranjan I. Prevention of nausea and vomiting in cisplatin-treated patients by a selective 5-hydroxytryptamine (5-HT3) receptor antagonist, ICS 205-930. Tumori. 1990;76(6):595-598.
Dogliotti, L. ; Faggiuolo, R. ; Berruti, A. ; Antonacci, R. A. ; Ortega, C. ; Lancranjan, I. / Prevention of nausea and vomiting in cisplatin-treated patients by a selective 5-hydroxytryptamine (5-HT3) receptor antagonist, ICS 205-930. In: Tumori. 1990 ; Vol. 76, No. 6. pp. 595-598.
@article{f0a8f0e407d446098a19d6685867083e,
title = "Prevention of nausea and vomiting in cisplatin-treated patients by a selective 5-hydroxytryptamine (5-HT3) receptor antagonist, ICS 205-930",
author = "L. Dogliotti and R. Faggiuolo and A. Berruti and Antonacci, {R. A.} and C. Ortega and I. Lancranjan",
year = "1990",
language = "English",
volume = "76",
pages = "595--598",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "6",

}

TY - JOUR

T1 - Prevention of nausea and vomiting in cisplatin-treated patients by a selective 5-hydroxytryptamine (5-HT3) receptor antagonist, ICS 205-930

AU - Dogliotti, L.

AU - Faggiuolo, R.

AU - Berruti, A.

AU - Antonacci, R. A.

AU - Ortega, C.

AU - Lancranjan, I.

PY - 1990

Y1 - 1990

UR - http://www.scopus.com/inward/record.url?scp=0025609985&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025609985&partnerID=8YFLogxK

M3 - Article

C2 - 2284699

AN - SCOPUS:0025609985

VL - 76

SP - 595

EP - 598

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 6

ER -